MetaADEDB 2.0 @ LMMD
lercanidipine
(ZDXUKAKRHYTAKV-UHFFFAOYSA-N)
Structure
SMILES
COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OC(CN(CCC(c1ccccc1)c1ccccc1)C)(C)C)C
Type(s)
Approved; Investigational
ATC code(s)
C08CA13; C09BB02; C09DB08
Molecular Formula:
C36H41N3O6
Molecular Weight:
611.727
Log P:
7.3304
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
1
TPSA:
113.69
CAS Number(s):
100427-26-7
Synonym(s)
1.
lercanidipine
2.
Lercadip
3.
Lerdip
4.
REC 15-2375
5.
REC-15-2375
6.
Zanidip
7.
lercanidipine hydrochloride
8.
methyl-1,1-dimethyl-2-(N-(3,3-diphenylpropyl)-N-methylamino)ethyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
External Link(s)
MeSHC060343
PubChem Compound65866
ChEBI135930
CHEMBLCHEMBL250270
DrugBankDB00528
DrugCentral4157
KEGGdr:D08111
Therapeutic Target DatabaseD0P6ZH
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainSIDER
2Acute Coronary SyndromeSIDER
3AgranulocytosisSIDER
4Alanine Aminotransferase IncreasedSIDER
5AlopeciaSIDER
6Angina PectorisSIDER
7AngioedemaSIDER
8AnorexiaSIDER
9AnxietySIDER
10Aphthous StomatitisSIDER
11ArthralgiaSIDER
12ArthritisSIDER
13Aspartate Aminotransferase IncreasedSIDER
14AstheniaSIDER
15AsthmaSIDER
16Blood and lymphatic system disordersSIDER
17Blood creatinine increasedSIDER
18Blood triglycerides increasedSIDER
19Blood urea increasedSIDER
20Bone marrow depressionSIDER
21BronchospasmSIDER
22Cerebrovascular accidentSIDER
23Chest PainSIDER
24CholestasisSIDER
25ConstipationSIDER
26Cramps of lower extremitiesSIDER
27DermatitisSIDER
28Diabetes MellitusSIDER
29DiabeticSIDER
30DiscomfortSIDER
31Dizziness11129125CTD
SIDER
32DysgeusiaSIDER
33DyspepsiaSIDER
34DysphoniaSIDER
35Ear and labyrinth disordersSIDER
36Edema11129125CTD
37Eosinophilic PneumoniaSIDER
38Erectile dysfunctionSIDER
39Erythema MultiformeSIDER
40ErythemaSIDER
41FatigueSIDER
42Feeling abnormalSIDER
43Flushing11129125CTD
SIDER
44Gamma-Glutamyltransferase IncreasedSIDER
45Gastrointestinal PainSIDER
46Gingival HypertrophySIDER
47GlossitisSIDER
48Headache11129125CTD
SIDER
49HepatitisSIDER
50HoarsenessSIDER
51HypersensitivitySIDER
52Hypotension symptomaticSIDER
53HypotensionSIDER
54IleusSIDER
55Kidney Diseases10945845CTD
56LeukocytosisSIDER
57LymphadenopathySIDER
58MalaiseSIDER
59MalnutritionSIDER
60Musculoskeletal discomfortSIDER
61MyalgiaSIDER
62Myocardial InfarctionSIDER
63MyositisSIDER
64NasopharyngitisSIDER
65NauseaSIDER
66NecrosisSIDER
67NervousnessSIDER
68NeutropeniaSIDER
69NocturiaSIDER
70OliguriaSIDER
71Oropharyngeal discomfortSIDER
72Oropharyngeal painSIDER
73PalpitationsSIDER
74PancreatitisSIDER
75PancytopeniaSIDER
76PemphigusSIDER
77Peptic UlcerSIDER
78Pharyngolaryngeal PainSIDER
79PolyuriaSIDER
80Precordial painSIDER
81Protein urine presentSIDER
82ProteinuriaSIDER
83PruritusSIDER
84RhinitisSIDER
85SerositisSIDER
86ShockSIDER
87SomnolenceSIDER
88Stevens-Johnson SyndromeSIDER
89StomatitisSIDER
90SyncopeSIDER
91TachycardiaSIDER
92TensionSIDER
93ThrombocytopeniaSIDER
94TinnitusSIDER
95Toxic Epidermal NecrolysisSIDER
96Urine output increasedSIDER
97UrticariaSIDER
98VasculitisSIDER
99VertigoSIDER
100VomitingSIDER
101jaundiceSIDER
102nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.